Aeolus Pharmaceuticals, Inc. (AOLS)
Develops antioxidant drugs to treat radiation exposure, chemical weapons injuries, and diseases like Parkinson's.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
AOLS is trading at $0.0001, positioned above both its 50- and 200-day moving averages. Analyst coverage appears minimal, so detailed rating data isn't available. The stock's technical positioning suggests it's in an uptrend relative to intermediate-term benchmarks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$15,208
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—